Details of the Target
General Information of Target
Target ID | LDTP01660 | |||||
---|---|---|---|---|---|---|
Target Name | Steroid hormone receptor ERR2 (ESRRB) | |||||
Gene Name | ESRRB | |||||
Gene ID | 2103 | |||||
Synonyms |
ERRB2; ESRL2; NR3B2; Steroid hormone receptor ERR2; ERR beta-2; Estrogen receptor-like 2; Estrogen-related receptor beta; ERR-beta; Nuclear receptor subfamily 3 group B member 2 |
|||||
3D Structure | ||||||
Sequence |
MSSDDRHLGSSCGSFIKTEPSSPSSGIDALSHHSPSGSSDASGGFGLALGTHANGLDSPP
MFAGAGLGGTPCRKSYEDCASGIMEDSAIKCEYMLNAIPKRLCLVCGDIASGYHYGVASC EACKAFFKRTIQGNIEYSCPATNECEITKRRRKSCQACRFMKCLKVGMLKEGVRLDRVRG GRQKYKRRLDSESSPYLSLQISPPAKKPLTKIVSYLLVAEPDKLYAMPPPGMPEGDIKAL TTLCDLADRELVVIIGWAKHIPGFSSLSLGDQMSLLQSAWMEILILGIVYRSLPYDDKLV YAEDYIMDEEHSRLAGLLELYRAILQLVRRYKKLKVEKEEFVTLKALALANSDSMYIEDL EAVQKLQDLLHEALQDYELSQRHEEPWRTGKLLLTLPLLRQTAAKAVQHFYSVKLQGKVP MHKLFLEMLEAKV |
|||||
Target Type |
Literature-reported
|
|||||
Target Bioclass |
Transcription factor
|
|||||
Family |
Nuclear hormone receptor family, NR3 subfamily
|
|||||
Subcellular location |
Nucleus
|
|||||
Function |
[Isoform 3]: Transcription factor that binds a canonical ESRRB recognition (ERRE) sequence 5'TCAAGGTCA-3' localized on promoter and enhancer of targets genes regulating their expression or their transcription activity. Plays a role, in a LIF-independent manner, in maintainance of self-renewal and pluripotency of embryonic and trophoblast stem cells through different signaling pathways including FGF signaling pathway and Wnt signaling pathways. Upon FGF signaling pathway activation, interacts with KDM1A by directly binding to enhancer site of ELF5 and EOMES and activating their transcription leading to self-renewal of trophoblast stem cells. Also regulates expression of multiple rod-specific genes and is required for survival of this cell type. Plays a role as transcription factor activator of GATA6, NR0B1, POU5F1 and PERM1. Plays a role as transcription factor repressor of NFE2L2 transcriptional activity and ESR1 transcriptional activity. During mitosis remains bound to a subset of interphase target genes, including pluripotency regulators, through the canonical ESRRB recognition (ERRE) sequence, leading to their transcriptional activation in early G1 phase. Can coassemble on structured DNA elements with other transcription factors like SOX2, POU5F1, KDM1A and NCOA3 to trigger ESRRB-dependent gene activation. This mechanism, in the case of SOX2 corecruitment prevents the embryonic stem cells (ESCs) to epiblast stem cells (EpiSC) transition through positive regulation of NR0B1 that inhibits the EpiSC transcriptional program. Also plays a role inner ear development by controlling expression of ion channels and transporters and in early placentation.; [Isoform 1]: Transcription factor that binds a canonical ESRRB recognition (ERRE) sequence 5'TCAAGGTCA-3' localized on promoter and enhancer of targets genes regulating their expression or their transcription activity. Positively regulates ESR1 transcriptional activity upon E2 stimulation.
|
|||||
TTD ID | ||||||
Uniprot ID | ||||||
DrugMap ID | ||||||
Ensemble ID | ||||||
HGNC ID | ||||||
ChEMBL ID |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
DBIA Probe Info |
![]() |
C91(1.06) | LDD1573 | [1] |
PAL-AfBPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
STS-2 Probe Info |
![]() |
N.A. | LDD0138 | [2] |
Competitor(s) Related to This Target
Competitor ID | Name | Cell line | Binding Site(Ratio) | Interaction ID | Ref |
---|---|---|---|---|---|
LDCM0369 | CL100 | HEK-293T | C91(1.06) | LDD1573 | [1] |
LDCM0372 | CL103 | HEK-293T | C91(1.20) | LDD1576 | [1] |
LDCM0373 | CL104 | HEK-293T | C91(1.01) | LDD1577 | [1] |
LDCM0376 | CL107 | HEK-293T | C91(1.28) | LDD1580 | [1] |
LDCM0377 | CL108 | HEK-293T | C91(0.51) | LDD1581 | [1] |
LDCM0381 | CL111 | HEK-293T | C91(1.17) | LDD1585 | [1] |
LDCM0382 | CL112 | HEK-293T | C91(0.88) | LDD1586 | [1] |
LDCM0385 | CL115 | HEK-293T | C91(1.13) | LDD1589 | [1] |
LDCM0386 | CL116 | HEK-293T | C91(0.91) | LDD1590 | [1] |
LDCM0389 | CL119 | HEK-293T | C91(1.35) | LDD1593 | [1] |
LDCM0391 | CL120 | HEK-293T | C91(0.99) | LDD1595 | [1] |
LDCM0394 | CL123 | HEK-293T | C91(1.00) | LDD1598 | [1] |
LDCM0395 | CL124 | HEK-293T | C91(0.98) | LDD1599 | [1] |
LDCM0398 | CL127 | HEK-293T | C91(1.09) | LDD1602 | [1] |
LDCM0399 | CL128 | HEK-293T | C91(0.96) | LDD1603 | [1] |
LDCM0402 | CL15 | HEK-293T | C91(1.17) | LDD1606 | [1] |
LDCM0403 | CL16 | HEK-293T | C91(1.02) | LDD1607 | [1] |
LDCM0415 | CL27 | HEK-293T | C91(1.08) | LDD1619 | [1] |
LDCM0416 | CL28 | HEK-293T | C91(0.87) | LDD1620 | [1] |
LDCM0418 | CL3 | HEK-293T | C91(1.11) | LDD1622 | [1] |
LDCM0428 | CL39 | HEK-293T | C91(1.14) | LDD1632 | [1] |
LDCM0429 | CL4 | HEK-293T | C91(0.94) | LDD1633 | [1] |
LDCM0430 | CL40 | HEK-293T | C91(0.86) | LDD1634 | [1] |
LDCM0443 | CL52 | HEK-293T | C91(1.03) | LDD1646 | [1] |
LDCM0455 | CL63 | HEK-293T | C91(1.03) | LDD1658 | [1] |
LDCM0456 | CL64 | HEK-293T | C91(0.97) | LDD1659 | [1] |
LDCM0469 | CL76 | HEK-293T | C91(0.88) | LDD1672 | [1] |
LDCM0481 | CL87 | HEK-293T | C91(1.39) | LDD1684 | [1] |
LDCM0482 | CL88 | HEK-293T | C91(0.86) | LDD1685 | [1] |
LDCM0494 | CL99 | HEK-293T | C91(1.19) | LDD1697 | [1] |
LDCM0495 | E2913 | HEK-293T | C91(1.23) | LDD1698 | [1] |
LDCM0468 | Fragment33 | HEK-293T | C91(1.05) | LDD1671 | [1] |
The Interaction Atlas With This Target
The Drug(s) Related To This Target
Approved
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Diethylstilbestrol | Small molecular drug | DB00255 | |||
Flavone | Small molecular drug | DB07776 |
Investigative
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Biochanin A | Small molecular drug | D0S9YX | |||
Daidzein | Small molecular drug | D0SY2M | |||
Dy131 | Small molecular drug | D06JPQ | |||
Genistein | Small molecular drug | DB01645 |
References